Vitamin K [EPC]

6214 reported adverse events

Drugs of this class: PHYTONADIONE ASCORBIC ACID, VITAMIN A PALMITATE, CHOLECALCIFEROL, THIAMINE HYDROCHLORIDE, RIBOFLAVIN-5 PHOSPHATE SODIUM, PYRIDOXINE HYDROCHLORIDE, NIACINAMIDE, DEXPANTHENOL, ALPHA-TOCOPHEROL ACETATE, VITAMIN K1, FOLIC ACID, BIOTIN, CYANOCOBALAMIN ARNICA MONTANA, CALENDULA OFFICINALIS, CARDUUS MARIANUS, GRAPHITES, HYPERICUM PERFORATUM, STAPHYSAGRIA, THIOSINAMINUM, VITAMIN K1 ASCORBIC ACID, VITAMIN A PALMITATE, CHOLECALCIFEROL, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5-PHOSPHATE SODIUM, PYRIDOXINE HYDROCHLORIDE, NIACINAMIDE, DEXPANTHENOL, ALPHA-TOCOPHEROL ACETATE, VITAMIN K1, FOLIC ACID, BIOTIN, CYANOCOBALAMIN VITAMIN K1 - PHYTONADIONE VITAMIN K1, PHYTONADIONE

These side effects are most commonly reported by patients taking drugs of the Vitamin K [EPC] class:

# Side effect Count
0 NAUSEA 390
1 FATIGUE 350
2 DYSPNOEA 320
3 DIARRHOEA 312
4 OFF LABEL USE 311
5 VOMITING 311
6 PYREXIA 257
7 SEPSIS 248
8 HEADACHE 233
9 DRUG INEFFECTIVE 232
See all common reactions for Vitamin K [EPC]

Drugs of the Vitamin K [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPENDICOLITH 78 0.6724
1 HAEMORRHAGE NEONATAL 6 0.1395
2 HYPER IGE SYNDROME 11 0.1264
3 CYSTIC FIBROSIS RELATED DIABETES 6 0.0750
4 TERMINAL ILEITIS 8 0.0630
5 FACTOR V INHIBITION 10 0.0575
6 VITAMIN K DEFICIENCY 15 0.0523
7 RENAL VASCULAR THROMBOSIS 6 0.0500
8 DISTAL INTESTINAL OBSTRUCTION SYNDROME 10 0.0478
9 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 217 0.0473
See all enriched reactions for Vitamin K [EPC]